Funds holding AGOMAB THERAPEUTICS SA
7 funds declare a position · 0 ETFs and 7 other funds · 30.2M $ · US00860C1027
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 981,184 | 10.6M $ | 0.23 % | as of Apr 30, 2026 · Original filing |
| 2 | Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 615,708 | 6.7M $ | 0.23 % | as of Apr 30, 2026 · Original filing |
| 3 | Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 507,877 | 8.1M $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 4 | Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 143,200 | 2.3M $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 5 | Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 129,200 | 2.1M $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 6 | Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 21,108 | 221.4K $ | 0.23 % | as of Mar 31, 2026 · Original filing |
| 7 | Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 9,100 | 145.8K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
Institutional managers
32 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,141,992 | 53.9M $ | as of Mar 31, 2026 |
| Sanofi | 2,783,096 | 29.2M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 2,465,348 | 25.9M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 2,053,233 | 21.5M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,618,000 | 17M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 1,550,000 | 16.3M $ | as of Mar 31, 2026 |
| ANDERA PARTNERS | 1,538,702 | 16.1M $ | as of Mar 31, 2026 |
| FMR LLC | 1,458,677 | 15.3M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 1,200,000 | 12.9M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 707,656 | 7.4M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 600,000 | 6.3M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 600,000 | 6.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 411,250 | 4.3M $ | as of Mar 31, 2026 |
| LMR Partners LLP | 300,000 | 3.1M $ | as of Mar 31, 2026 |
| SEVEN GRAND MANAGERS, LLC | 200,000 | 2.1M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 156,250 | 1.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 95,233 | 999K $ | as of Mar 31, 2026 |
| Pfizer Inc | 75,000 | 813.8K $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 75,000 | 786.8K $ | as of Mar 31, 2026 |
| Bellevue Group AG | 50,000 | 524.5K $ | as of Mar 31, 2026 |
| Laurion Capital Management LP | 50,000 | 524.5K $ | as of Mar 31, 2026 |
| SECTORAL ASSET MANAGEMENT INC | 43,500 | 477.3K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 35,739 | 374.9K $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 35,000 | 367.2K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 35,000 | 367.2K $ | as of Mar 31, 2026 |